Supplemental Oxygen for Symptomatic Relief in People with Serious Respiratory Illness: a Systematic Review and Meta-analysis

Overview

Journal Eur Respir Rev

Specialty Pulmonary Medicine

Date 2025 Mar 5

PMID 40044186

Authors

Zainab Ahmadi

Natasha E Smallwood

Anne-Marie Russell

Ravijyot Saggu

Lorena Romero

Anne E Holland

Magnus Ekstrom

Affiliations

Soon will be listed here.

Abstract

Background: People with serious respiratory illness frequently have a high symptom burden and may be prescribed supplemental oxygen therapy with the aims of reducing the severity of breathlessness and improving health-related quality of life (HRQoL). This systematic review and meta-analysis aimed to assess the effectiveness of oxygen therapy no oxygen on 1) breathlessness, 2) HRQoL and 3) adverse events.

Methods: A comprehensive search was performed in Embase, Medline and the Cochrane Central Register of Controlled Trials for randomised controlled trials published prior to June 2022. We used the Cochrane Risk of Bias Tool for appraising the studies and conducted random-effect meta-analyses when appropriate. We pooled effects recorded on different scales as standardised mean differences (SMDs) with 95% confidence intervals. Lower SMDs indicated decreased breathlessness or HRQoL. We assessed the certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation framework.

Results: We found that supplemental oxygen (compared with sham air or no treatment), reduced breathlessness intensity during laboratory exercise testing (SMD -0.75, 95% CI -1.23--0.28, 12 randomised control trials (RCTs), 245 participants), but had no shown effect on breathlessness measured in daily life (SMD -0.08, 95% CI -0.41-0.26, one RCT, 213 participants) or HRQoL (SMD -0.06, -0.17-0.05, 14 RCTs, 1062 participants). Few or no adverse events related to oxygen therapy were reported. For all the outcomes, the certainty of evidence was low.

Conclusions: Oxygen improved exertional breathlessness in laboratory-based exercise studies but was not shown to improve breathlessness or HRQoL in daily life.

References

Innocenti Bruni G, Gigliotti F, Binazzi B, Romagnoli I, Duranti R, Scano G . Dyspnea, chest wall hyperinflation, and rib cage distortion in exercising patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc. 2012; 44(6):1049-56. DOI: 10.1249/MSS.0b013e318242987d. View

Ekstrom M, Elmberg V, Lindow T, Wollmer P . Breathlessness measurement should be standardised for the level of exertion. Eur Respir J. 2018; 51(5). DOI: 10.1183/13993003.00486-2018. View

Uronis H, Ekstrom M, Currow D, McCrory D, Samsa G, Abernethy A . Oxygen for relief of dyspnoea in people with chronic obstructive pulmonary disease who would not qualify for home oxygen: a systematic review and meta-analysis. Thorax. 2014; 70(5):492-4. DOI: 10.1136/thoraxjnl-2014-205720. View

Abernethy A, Currow D, Frith P, Fazekas B . Prescribing palliative oxygen: a clinician survey of expected benefit and patterns of use. Palliat Med. 2005; 19(2):168-70. DOI: 10.1177/026921630501900219. View

Holland A, Spathis A, Marsaa K, Bausewein C, Ahmadi Z, Burge A . European Respiratory Society clinical practice guideline on symptom management for adults with serious respiratory illness. Eur Respir J. 2024; 63(6). DOI: 10.1183/13993003.00335-2024. View

Bausewein C, Schunk M, Schumacher P, Dittmer J, Bolzani A, Booth S . Breathlessness services as a new model of support for patients with respiratory disease. Chron Respir Dis. 2017; 15(1):48-59. PMC: 5802660. DOI: 10.1177/1479972317721557. View

Foo J, Landis S, Maskell J, Oh Y, van der Molen T, Han M . Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries. PLoS One. 2016; 11(4):e0152618. PMC: 4836731. DOI: 10.1371/journal.pone.0152618. View

Spielmanns M, Fuchs-Bergsma C, Winkler A, Fox G, Kruger S, Baum K . Effects of Oxygen Supply During Training on Subjects With COPD Who Are Normoxemic at Rest and During Exercise: A Blinded Randomized Controlled Trial. Respir Care. 2014; 60(4):540-8. DOI: 10.4187/respcare.03647. View

Schaeffer M, Ryerson C, Ramsook A, Molgat-Seon Y, Wilkie S, Dhillon S . Effects of hyperoxia on dyspnoea and exercise endurance in fibrotic interstitial lung disease. Eur Respir J. 2017; 49(5). DOI: 10.1183/13993003.02494-2016. View

10.

Hutchinson A, Pickering A, Williams P, Bland J, Johnson M . Breathlessness and presentation to the emergency department: a survey and clinical record review. BMC Pulm Med. 2017; 17(1):53. PMC: 5360046. DOI: 10.1186/s12890-017-0396-4. View

11.

Sava F, Perrault H, Brouillard C, Darauay C, Hamilton A, Bourbeau J . Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol. COPD. 2012; 9(4):395-400. DOI: 10.3109/15412555.2012.674164. View

12.

Lindell K, Collins E, Catanzarite L, Garvey C, Hernandez C, McLaughlin S . Equipment, access and worry about running short of oxygen: Key concerns in the ATS patient supplemental oxygen survey. Heart Lung. 2019; 48(3):245-249. DOI: 10.1016/j.hrtlng.2018.12.006. View

13.

Dipla K, Boutou A, Markopoulou A, Pitsiou G, Papadopoulos S, Chatzikosti A . Exertional Desaturation in Idiopathic Pulmonary Fibrosis: The Role of Oxygen Supplementation in Modifying Cerebral-Skeletal Muscle Oxygenation and Systemic Hemodynamics. Respiration. 2021; 100(6):463-475. DOI: 10.1159/000514320. View

14.

Swan F, Newey A, Bland M, Allgar V, Booth S, Bausewein C . Airflow relieves chronic breathlessness in people with advanced disease: An exploratory systematic review and meta-analyses. Palliat Med. 2019; 33(6):618-633. DOI: 10.1177/0269216319835393. View

15.

Blinderman C, Homel P, Billings J, Tennstedt S, Portenoy R . Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage. 2009; 38(1):115-23. DOI: 10.1016/j.jpainsymman.2008.07.006. View

16.

Moore R, Berlowitz D, Denehy L, Pretto J, Brazzale D, Sharpe K . A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax. 2010; 66(1):32-7. DOI: 10.1136/thx.2009.132522. View

17.

Bjorklund F, Ekstrom M . Adverse Effects, Smoking, Alcohol Consumption, and Quality of Life during Long-Term Oxygen Therapy: A Nationwide Study. Ann Am Thorac Soc. 2022; 19(10):1677-1686. PMC: 9528738. DOI: 10.1513/AnnalsATS.202110-1174OC. View

18.

Alison J, McKeough Z, Leung R, Holland A, Hill K, Morris N . Oxygen compared to air during exercise training in COPD with exercise-induced desaturation. Eur Respir J. 2019; 53(5). DOI: 10.1183/13993003.02429-2018. View

19.

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

20.

Dean N, Brown J, Himelman R, Doherty J, Gold W, Stulbarg M . Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis. 1992; 146(4):941-5. DOI: 10.1164/ajrccm/146.4.941. View